Physician profile
Reed T Hall
NPI 1851516827
$5,151.99
in general payments reported to CMS, 2019-2025
9 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,468 · 2020: $625 · 2021: $1,267 · 2022: $39.36 · 2023: $166 · 2024: $400 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $473 · Food and Beverage: $258 · Education: $20.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $473.49 |
| Food and Beverage | $258.27 |
| Education | $20.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $3,489.95 | 2019-2025 | |
| Dentsply Sirona INC | $667.49 | 2021-2022 | |
| Patterson Companies, INC. | $625.24 | 2021-2022 | |
| 3m Company | $162.15 | 2019-2023 | 3m Filtek, Scotchbond Universal Plus, Filtek |
| Solventum Corporation | $92.06 | 2024-2025 | Filtek, Scotchbond Universal, 3m Relyx |
| Ultradent Products INC | $62.49 | 2024 | Opalescence |
| Hu-Friedy Mfg. Co., LLC | $20.57 | 2024 | Ims |
| Actelion Pharmaceuticals US, INC. | $18.46 | 2023 | Opsumit, Uptravi |
| Nobel Biocare USA | $13.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reed Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.